- WU Q, Wu H, Hu Y, Zheng X, et al
Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients.
Antiviral Res. 2025 Jan 24:106092. doi: 10.1016/j.antiviral.2025.106092.
PubMed Abstract available - HANKINS RJ, Handke L, Fey PD, Cavalieri RJ, et al
Prospective, crossover, comparative study of two methods of chlorhexidine bathing.
Infect Control Hosp Epidemiol. 2025 Jan 30:1-6. doi: 10.1017/ice.2024.
PubMed Abstract available - PISCHEL L, Aguolu OG, Ahmed N, Campbell MM, et al
Social mixing patterns of United States healthcare personnel at a quaternary health center: a prospective observational study.
Infect Control Hosp Epidemiol. 2025 Jan 30:1-9. doi: 10.1017/ice.2024.
PubMed Abstract available - ZSIGMOND B, Trecchi N, Ladhani SN, Doerholt K, et al
Early outpatient treatment of SARS-COV-2 infection in non-hospitalised high-risk paediatric patients in London, UK.
J Infect. 2025;90:106425.
PubMed - BENNETT C, Chau G, Clayton E, Chu L, et al
Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial.
J Infect. 2025 Jan 26:106428. doi: 10.1016/j.jinf.2025.106428.
PubMed Abstract available - LI J, Yan H, Li J, Ling F, et al
Low Neutralization of SARS-CoV-2 Omicron BA5248, XBB15 and JN1 by Homologous Booster and Breakthrough Infection.
J Med Virol. 2025;97:e70189.
PubMed Abstract available
Correction to "Serum-Derived Bovine Immunoglobulin Treatment in COVID-19 Is Associated With Faster Resolution of Symptoms: A Randomized Pilot Clinical Trial".
J Med Virol. 2025;97:e70202.
PubMed- WANG Y, Xia B, Gao Z
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.
J Virol. 2025 Jan 29:e0204924. doi: 10.1128/jvi.02049.
PubMed Abstract available - LIU C, Kong N, Liu H, Zhang Y, et al
FSTL1 and TLR4 interact with PEDV structural proteins to promote virus adsorption to host cells.
J Virol. 2025;99:e0183724.
PubMed Abstract available - LYTRAS S, Lamb KD, Ito J, Grove J, et al
Pathogen genomic surveillance and the AI revolution.
J Virol. 2025 Jan 29:e0160124. doi: 10.1128/jvi.01601.
PubMed Abstract available - DUGUAY BA, Tooley TH, Pringle ES, Rohde JR, et al
A yeast-based reverse genetics system to generate HCoV-OC43 reporter viruses encoding an eighth subgenomic RNA.
J Virol. 2025 Jan 30:e0167124. doi: 10.1128/jvi.01671.
PubMed Abstract available - SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.
J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
PubMed Abstract available - ANDERER S
COVID-19 Tied to Long-Term Kidney Function Decline.
JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28058.
PubMed - MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
Lancet. 2025;405:314-328.
PubMed Abstract available - KERR S, Robertson C, Sheikh A
Undervaccination and severe COVID-19 outcomes - Authors' reply.
Lancet. 2025;405:302.
PubMed - MORRIS JA
Undervaccination and severe COVID-19 outcomes.
Lancet. 2025;405:301-302.
PubMed - JOFFE AR
Undervaccination and severe COVID-19 outcomes.
Lancet. 2025;405:301.
PubMed - DUNCAN CJA
Antibody testing to predict SARS-CoV-2 risk in immunocompromised people.
Lancet. 2025;405:276-278.
PubMed - RAHARINIRINA NA, Gubela N, Bornigen D, Smith MR, et al
SARS-CoV-2 evolution on a dynamic immune landscape.
Nature. 2025 Jan 29. doi: 10.1038/s41586-024-08477.
PubMed Abstract available - MORALES AE, Dong Y, Brown T, Baid K, et al
Bat genomes illuminate adaptations to viral tolerance and disease resistance.
Nature. 2025 Jan 29. doi: 10.1038/s41586-024-08471.
PubMed Abstract available
Antiviral Res
Comments
Post a Comment